Following the initiative of other leading scientific journals, we believe that it is timely, important, and appropriate to share as soon as possible with our Journal of Hepatology readers all information available on the possible impact of COVID-19 (coronavirus) on the liver and affected patient…
Europe’s Beating Cancer Plan needs a thorough prevention pillar to tackle challenges common to all non-communicable diseases (NCDs), reads a statement by 30+ health organisations. NCDs, such as cardiovascular disease, cancer, respiratory diseases and diabetes, undermine people’s health and well-b…
Over 600 delegates from 44 countries gathered in Prague at the EASL Liver Cancer Summit 2020 to discuss latest developments and the future of liver cancer research. Organised annually by EASL, the European Association for the Study of the Liver, the Liver Cancer Summit 2020 edition provided an in…
Every year, the EASL Postgraduate course highlights many clinical practice dilemmas and engages the audience with world-renowned experts on how to make the best management decisions to help patients with liver disease. This year’s postgraduate course at the International Liver Congress™ 2019 was …
EASL expresses deep sadness at the sudden passing of Prof. Fritz von Weizsäcker, who died on 19 November 2019 at the age of 59. Prof. von Weizsäcker was an expert for gastroenterology, hepatology, oncology, and infectiology at Schlosspark Clinic in Berlin. He was an active, engaged, and much love…
We’re pleased to announce the launch of our improved multi-disciplinary eLearning hub, EASL Campus, designed to help you develop your hepatology and liver-related disease knowledge through a variety of open-access, high quality and interactive resources tailored to your specialism and job functio…
EASL member and former secretary-general (2002-2003) Professor Jordi Bruix was honoured with the Distinguished Achievement Award at The Liver Meeting® 2019, held this week by the American Association for the Study of Liver Diseases (AASLD) in Boston. The award, which is presented to only one indi…
SHARE YOUR RESEARCH discuss your findings with other professionals NETWORK WITH EXPERTS interact with an international community & Key Opinion Leaders 9,000 experts in liver disease BOOST YOUR CAREER publication in the Journal of Hepatology supplement inclusion in the scientific programme BE RECO…
Take advantage of the EASL funding and mentorship opportunities to attain the next level in your research. “The EASL Hepatology Fellowships are a great opportunity, not only to get financial support, but also to attend and present results at the ILC, an event that gathers worldwide experts in the…
On the 1st of September 2019, Professor Karl-Hermann Meyer zum Büschenfelde passed away shortly before his 90th birthday. He will be remembered as a pioneer in liver immunology and as one of the most prominent clinician scientists and mentors within the international hepatology community. “MzB” a…
